Sun Biopharma Inc. (SNBP): Price and Financial Metrics
SNBP Price/Volume Stats
| Current price | $3.45 | 52-week high | $10.00 |
| Prev. close | $3.44 | 52-week low | $2.37 |
| Day low | $3.36 | Volume | 32,300 |
| Day high | $3.49 | Avg. volume | 26,926 |
| 50-day MA | $3.11 | Dividend yield | N/A |
| 200-day MA | $4.05 | Market Cap | 33.29M |
SNBP Stock Price Chart Interactive Chart >
Sun Biopharma Inc. (SNBP) Company Bio
Sun BioPharma Inc. engages in the development of disruptive therapeutics for medical purposes. It focuses on development programs that target diseases of the pancreas, including pancreatic cancer and pancreatitis. The company was founded by Michael Cullen and Thomas Neenan on September 21, 2011 and is headquartered in Waconia, MN.
Latest SNBP News From Around the Web
Below are the latest news stories about Sun BioPharma Inc that investors may wish to consider to help them evaluate SNBP as an investment opportunity.
Sun Biopharma prices $10.5M equity offeringSun BioPharma (SNBP) has priced public offering of 2,545,454 common stock and the same number of warrants at $4.125/share and warrant, for gross proceeds of ~$10.5M.Each warrant entitles the holder to purchase one share of common stock at $4.54 /share. The company will kick-off trading today on Nasdaq Capital Market.... |
IPO Update: Sun BioPharma Presents IPO TermsQuick Take Sun BioPharma (SNBP) intends to raise $10 million from the sale of its common stock in an IPO, according to an amended registration statement. The company is developing a treatment candidate for pancreatic cancer. SNBP is a thinly capitalized firm operating in a very difficult area of research,... |
SNBP Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | N/A |
| YTD | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
Loading social stream, please wait...